Table 1.
Therapies | Strategies | Targets | References |
---|---|---|---|
DCA | inhibit PDK and activate PDH | mitochondrial TCA | [76] |
vitamin K2 | promote the glycolysis | mitochondrial TCA | [78] |
AS-ODNs | improve drug sensitivity induce apoptosis |
BCL-2, NRB1 | [84,85] |
siRNA | improve drug sensitivity induce apoptosis |
BCL-2, NRB1 | [66] |
metformin | induce apoptosis | mitochondria | [77] |
silibinin | induce apoptosis | mitochondria | [86] |
baicalein | induce apoptosis | mitochondria | [100] |
resveratrol | induce apoptosis | mitochondria | [104,105] |
CXC195 | induce apoptosis | TMP analog | [79] |
TRAIL | induce apoptosis | mitochondria | [106] |
UVA | damage mitochondria | mitochondria | [110] |
AS-ODNs, antisense oligodeoxynucleotides; siRNA, small interfering RNA; TMP, tetramethylpyrazine; TRAIL, tumor necrosis factor (TNF)-related apoptosis-inducing ligand; DCA, dichloroacetate; PDK, pyruvate dehydrogenase kinase; PDH, pyruvate dehydrogenase; UVA, ultraviolet A.